Risk factors of long-term survival and recurrence after curative resection of hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 52, Issue 62, 2005, Pages 552-557

  Hanazaki, Kazuhiro ^a   Matsushita, Akimasa ^a   Nakagawa, Kan ^a   Misawa, Ryosuke ^a   Amano, Jun ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Indocyanine green retention rate; Multivariate analysis; Prognostic factor; Stage IV; Surgery; Univariate analysis

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HOSPITAL DISCHARGE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL TIME; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; COLORING AGENTS; FEMALE; HEPATECTOMY; HEPATITIS B SURFACE ANTIGENS; HUMANS; INDOCYANINE GREEN; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 16344362658     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Lau H, Fan ST, Wong J: Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer 1998; 83:2302-2311.
2. Faster J, Garcia-Valdecasas JC, Grande L, Tabet J, Bruix J, Anglada T, Taura P, Lacy AM, Gonzalez X, Vilana R, Bru CB, Sole M, Visa J: Hepatocellular carcinoma and cirrhosis: Results of surgical treatment in a European series. Ann Surg 1996; 223:297-302.
3. The Liver Cancer Study Group of Japan: Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994; 74:2772-2780.
4. Kosuge T, Makuuchi M, Takayama T, Yamamoto J, Shimada K, Yamasaki S: Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology 1993; 40:328-332.
5. Stuart KE, Anand AJ, Jenkins RL: Hepatocellular carcinoma in the United States. Cancer 1996; 77:2217-2222.
6. Nagasue N: Liver resection for hepatocellular carcinoma: indications, techniques, complications, and prognostic factors. J Hepatobiliary Pancreat Surg 1998; 5:7-13.
7. Sugioka A, Tsuzuki T, Kanal T: Postresection prognosis of patients with hepatocellular carcinoma. Surgery 1993; 113:612-618.
8. Lise M, Bacchetti S, Pian PD, Nitti D, Pilati PL, Pigato P: Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: Results in a series of 100 Italian patients. Cancer 1998; 82:1028-1036.
9. Ikeda Y, Shimada M, Hasegawa H, Gion T, Kajiyama K, Shirabe K, Yanaga K, Takenaka K, Sugimachi K: Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology 1998; 27:1567-1571.
10. Masutani S, Sasaki Y, Imaoka S, Iwamoto S, Ohashi I, Kameyama M, Kabuto T, Ishikawa O, Furukawa H, Koyama H: The prognostic significance of surgical margin in liver resection of patients with hepatocellular carcinoma. Arch Surg 1994; 129:1025-1030.
11. Izumi R, Shimizu K, Li T, Yagi M, Matsui O, Nonomura A, Miyazaki I: Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994; 106:720-727.
12. Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T, Fujimoto J, Oriyama T, Furukawa K, Kawamura E: Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer 1990; 65:1104-1110.
13. Nagasue N, Kohno H, Chang YC, Taniura H, Yamanoi A, Uchida M, Kimoto T, Takemoto Y, Nakamura T, Yukaya H: Liver resection for hepatocellular carcinoma: Results of 229 consecutive patients during 11 years. Ann Surg 1993; 217:375-384.
14. Gozzetti G, Mazziotti A, Cavallari A, Bellusci R, Belondi L, Grigioni W, Bragaglia R, Grazi GL, De Raffele E: Clinical experience with hepatic resections for hepatocellular carcinoma in patients with cirrhosis. Surg Gynecol Obstet 1988; 166:503-510.
15. Nagao T, Inoue S, Goto S, Mizuta T, Omori Y, Kawano N, Morioka Y: Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg 1987; 205:33-40.
16. Nonami T, Harada A, Kurokawa T, Nakao A, Takagi H: Hepatic resection for hepatocelluar carcinoma. Am J Surg 1997; 173:288-291.
17. Shimada M, Takenaka K, Fujiwara Y, Gion T, Kajiyama K, Maeda T, Shirabe K, Sugimachi K: Des-γ-carboxy prothrombin and α-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma. Cancer 1996; 78:2094-2100.
18. Kanematsu T, Matsumata T, Shirabe K, Sugimachi K, Sakamoto S, Nawata H, Hasuo K, Honda H, Masuda K: A comparative study of hepatic resection and transcatheter arterial embolization for the treatment of primary hepatocellular carcinoma. Cancer 1993; 71:2181-2186.
19. Shirabe K, Shimada M, Kajiyama K, Gion T, Ikeda Y, Hasegawa H, Taguchi K, Takenaka K, Sugimachi K: Clinicopathologic features of patients with hepatocellular carcinoma surviving > 10 years after hepatic resection. Cancer 1998; 83:2312-2316.
20. Fijimoto J, Okamoto E, Yamanaka N, Tanaka T, Tanaka W: Adverse effect of perioperative blood transfusion on survival after hepatic resection for hepatocellular carcinoma. Hepatogastroenterology 1997; 44:1390-1396.
21. Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, Kubota K, Zucchi A: No-mortality liver resection for hepatoceUular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999; 134:984-992.
22. Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J: Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 1999; 229:322-330.
23. Liver Cancer Study Group of Japan: The general rules for the clinical and pathological study of primary liver cancer. 3rd Edition. Tokyo: Kanehara Co. Ltd., 1992.
24. Sobin LH, Wittekind Ch (Eds.): TNM Classification of malignant tumors. 5th Edition. New York: John Wiley, 1997.
25. Makuuchi M, Hasegawa H, Yamazaki S: Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 1985; 161:346-350.
26. Couinaud C: Bases anatomiques des hepatectomies gauche at droite reglees: Techniques qui en decoulent. J Chir 1954; 70:933-966.
27. Cox DR: Regression models and life tables. JR Stat Soc Ser B 1972; 34:187-220.
28. Poon RTP, Fan ST, Wong J: Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000; 232:10-24.
29. Ikai I, Yamaoka Y, Yamamoto Y, Ozaki N, Sakai Y, Satoh S, Shinkura N, Yamamoto M: Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Ann Surg 1998; 227:433-439.
30. Ohkubo T, Yamamoto J, Sugawara Y, Shimada K, Yamasaki S, Makuuchi M, Kosuge T: Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg 2000; 191:657-660.
31. Fan ST, Ng IO, Poon RT, Lo CM, Liu CL, Wong J: Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Arch Surg 1999; 134:1124-1130.
32. Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S: Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000; 88:538-543.
33. Shimada M, Takenaka K, Kawahara N, Kajiyama K, Yamamoto K, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K: Surgical treatment strategy for patients with stage IV hepatocellular carcinoma. Surgery 1996; 119:517-522.
34. Nakakura EK, Choti MA: Management of hepatocellular carcinoma. Oncology 2000; 14:1085-1098.
35. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T: Criteria for safe hepatic resection. Am J Surg 1995; 169:589-594.
36. Yamanaka N, Okamoto E, Kuwata K, Tanaka N: A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg 1984; 200:658-663.
37. Hasegawa S, Yamasaki N, Hiwaki T, Sako K, Komorizono Y, Baba Y, Imamura Y, Kubozono O, Yoshida A, Arima T: Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer 1999; 86:1682-1690.
38. Partensky C, Sassolas G, Henry L, Paliard P, Maddern GJ: Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study. Arch Surg 2000; 135:1298-1300.
39. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, Shimada K, Sakamoto M, Hirohashi S, Ohashi Y, Kakizoe T: Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomized trial. Lancet 2000; 356:802-807.